Consortium develops technology to identify genetic and environmental causes of cancers

October 26, 2016

Oct. 24, 2016, Lebanon, N.H. - Through the development of a novel, inexpensive genotyping microarray, the OncoArray, Dartmouth investigators have led a key collaborative research study that will revolutionize our knowledge of the causes of common cancers.

The OncoArray is comprised of 230,000 single nucleotide polymorphisms (SNPs), each representing a difference in a single DNA building block, or nucleotide. These variations act as biological markers, helping scientists locate genes that are associated with cancer and leading to a better understanding of risk of development and inheritance of disease genes.

One primary difficulty relates to the need to coordinate a consortium that has collected SNP samples and data from throughout the world. To resolve this challenge, Dartmouth researchers, led by Christopher Amos, PhD, Dartmouth Professor and Interim Director of Norris Cotton Cancer Center, formed a consortium of multiple institutions, funded by multiple sources. The consortium has developed approaches for quality control of SNP selection, site selection, and genotyping and ancestry analysis accuracy. "We are seeking to understand the causes of common cancer including genetic and environmental, and their interactions," explains Amos. Details of the consortium's goal and purpose, "The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers," were recently published in Cancer Epidemiology Biomarkers.

The consortium genotyped 447,705 samples out of a total of 494,763 SNPs that passed quality control steps with a success rate of 97%. Results from these analyses will enable researchers to identify and map new susceptibility loci associated with multiple cancers, assess disease-specific risk, and model genetic, environmental, and lifestyle-related exposures. "The new platform we developed for genotyping was highly successful in allowing us to query over 440,000 people with high accuracy and low cost. This approach will allow us to identify a very large number of new genetic factors influencing cancer risk and to tease apart the roles of environmental factors," explains Amos. "Preliminary studies have identified more than 100 new loci contributing to common cancers including lung, colon, breast, ovarian, and prostate cancers. Additionally, the new technology was applied to studies of glioma, head and neck, and testicular cancers and has provided key insights."

Amos anticipates that several dozen papers will result from consortium analyses. The first of these papers that analyzes susceptibility loci for oral cavity and pharyngeal cancer, has already published this month in Nature Genetics.
-end-
About Norris Cotton Cancer Center at Dartmouth-Hitchcock

Norris Cotton Cancer Center combines advanced cancer research at Dartmouth's Geisel School of Medicine with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center in Lebanon, NH, at Dartmouth-Hitchcock regional locations in Manchester, Nashua and Keene, NH, and St. Johnsbury, VT, and at partner hospitals throughout New Hampshire and Vermont. It is one of 45 centers nationwide to earn the National Cancer Institute's "Comprehensive Cancer Center" designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.

Dartmouth-Hitchcock Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.